2026 年至 2032 年翻新医疗图像设备市场（按产品类型、应用、最终用户和地区）

翻新医疗图像设备市场估值－2026 年至 2032 年

翻新医疗图像设备的价格通常比新设备低40%到60%，因此，它成为一个相当有吸引力的选择，尤其对于预算有限的医疗机构而言。根据Verified Market Research分析师预测，到2024年，翻新医疗图像设备市场规模将达到约158.8亿美元，预测期内将达到379.4亿美元。

由于医疗设备的再製造减少了废弃物併节约了资源，环保实践趋势正在影响市场，这将有助于市场在 2026 年至 2032 年期间以 11.50% 的复合年增长率增长。

翻新医疗图像设备市场定义/概述

翻新医疗图像设备是指经过修復，使其安全和性能标准接近原厂设备的医学影像设备。这些设备经过全面的翻新流程，包括拆卸、清洗、维修、更换磨损零件、软体更新以及严格的品质测试。

与可能以「原样」出售且不提供保固的二手设备不同，翻新设备享有经销商或原始製造商的保固支援。此流程确保设备在临床应用中安全有效，对于希望升级影像处理能力而又无需购买新设备的医疗机构而言，翻新设备是经济实惠的选择。

由于其价格实惠和可靠性，对翻新医疗图像设备的需求不断增加，尤其是在预算有限的医疗机构中。

慢性病的增加如何影响翻新医疗图像设备的需求？

慢性病的增加对翻新医疗图像设备的需求产生了重大影响。根据世界卫生组织 (WHO) 的报告：

据预测，到2050年，全球60岁以上人口将翻一番，导致心臟病、糖尿病和关节炎等与老龄化相关的疾病发生率上升。这种人口结构变化将需要增强诊断能力，并促使医疗机构寻求经济高效的解决方案来获得先进的影像技术。约70%的医疗服务提供者面临预算限制，这促使他们考虑将翻新设备作为价格高昂的新设备的可行替代方案。

此外，翻新过程确保这些设备符合安全和性能标准，使医疗保健提供者无需花费大量资本支出即可改善患者照护。因此，对翻新医疗图像设备的需求是由对可访问、负担得起的诊断工具的需求所驱动，以有效管理日益加重的慢性病负担。

最终用户的负面看法如何影响翻新医疗图像设备的采用率？

终端用户的负面认知会显着影响翻新医疗图像设备的采用率。使用者普遍对翻新医疗设备的品质、安全性和可靠性表示担忧，这使得许多医疗专业人士不愿购买。一份报告显示，约60%的医院表示，对翻新产品的有效性和耐用性的担忧是其采用的主要障碍。

此外，对潜在隐患的担忧以及翻新流程的不确定性也加剧了这种犹豫。目标商标产品製造商 (OEM) 警告医疗机构，他们将不再为旧型号提供支持，这进一步加剧了这些担忧，阻碍了他们购买翻新设备。因此，翻新流程的透明度以及品质和性能保证对于解决这些担忧至关重要。如果没有有效的策略来解决这些问题，翻新医疗图像设备市场的成长可能会受到阻碍。

目录

第 1 章全球翻新医疗图像设备市场简介

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球翻新医疗图像设备市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

5. 全球翻新医疗图像设备市场（按产品）

• 概述
• X光设备
• 超音波诊断设备
• CT扫描仪
• 核磁共振造影系统
• 其他的

6. 全球翻新医疗图像设备市场（按应用）

• 概述
• 肿瘤学
• 循环系统
• 妇科
• 整形外科
• 其他的

7. 全球翻新医疗图像设备市场（依最终用户）

• 概述
• 医院
• 诊断影像中心
• 门诊医疗中心
• 其他的

8. 全球翻新医疗图像设备市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 其他的
  • 拉丁美洲
  • 中东和非洲

第九章 翻新医疗图像设备的全球竞争格局

• 概述
• 各公司市场排名
• 重点发展策略

第十章 公司简介

• GE Healthcare
• Block Imaging
• Agito Medical A/S
• Siemens Healthcare systems
• Integrity Medical Systems
• Koninklijke Philips NV
• Everx Pvt Ltd.
• JAPAN CENTRAL MEDICAL, INC
• CURA Healthcare
• Radiology Oncology Systems, Inc.

第十一章 重大进展

• 产品发布/开发
• 合併与收购
• 业务扩展
• 伙伴关係与合作

第十二章 附录

• 相关调查

Refurbished Medical Imaging Equipment Market Valuation - 2026-2032

Refurbished medical imaging equipment is typically available at 40% to 60% less than the price of new devices, making it an attractive option for healthcare facilities, especially those with budget constraints. According to the analyst from Verified Market Research, the refurbished medical imaging equipment market is estimated to reach a valuation of USD 37.94 Billion over the forecast subjugating around USD 15.88 Billion valued in 2024.

The trend towards eco-friendly practices is influencing the market, as refurbishing medical devices reduces waste and conserves resources. It enables the market to grow at a CAGR of 11.50% from 2026 to 2032.

Refurbished Medical Imaging Equipment Market: Definition/Overview

Refurbished medical imaging equipment refers to medical imaging systems that have been restored to meet safety and performance standards comparable to their original condition. These devices undergo a comprehensive refurbishment process, which includes disassembly, cleaning, repair, replacement of worn parts, software updates, and rigorous quality testing.

Unlike used equipment, which may be sold "as is" without guarantees, refurbished devices come with warranties provided by the reseller or the original manufacturer. This process ensures that the equipment is safe and effective for clinical use, making it a cost-effective alternative for healthcare facilities looking to upgrade their imaging capabilities without the expense of new devices.

Refurbished medical imaging equipment is increasingly sought after due to its affordability and reliability, especially in resource-constrained settings where budget considerations are paramount.

How is the Increasing Prevalence of Chronic Diseases Influencing the Demand for Refurbished Medical Imaging Devices?

The increasing prevalence of chronic diseases is significantly influencing the demand for refurbished medical imaging devices. As reported by the World Health Organization (WHO),

the aging population is linked to a rise in chronic conditions, with projections indicating that by 2050, the global population aged 60 years and older will double, resulting in a higher incidence of age-related diseases such as heart disease, diabetes, and arthritis. This demographic shift necessitates enhanced diagnostic capabilities, leading healthcare facilities to seek cost-effective solutions for acquiring advanced imaging technologies. It has been observed that approximately 70% of healthcare providers are facing budget constraints, prompting them to consider refurbished equipment as a viable alternative to new devices, which can be prohibitively expensive.

Furthermore, the refurbishment process ensures that these devices meet safety and performance standards, allowing healthcare providers to enhance patient care without incurring significant capital expenditures. Consequently, the demand for refurbished medical imaging devices is being driven by the need for accessible and affordable diagnostic tools to manage the growing burden of chronic diseases effectively.

In What Ways does the Negative Perception of End-Users Affect the Adoption Rates of Refurbished Medical Imaging Equipment?

The negative perception of end-users significantly affects the adoption rates of refurbished medical imaging equipment. Concerns regarding the quality, safety, and reliability of these devices are commonly expressed, leading many healthcare providers to hesitate in their purchasing decisions. According to a report, approximately 60% of hospitals cite worries about the effectiveness and durability of refurbished equipment as a primary barrier to adoption.

Additionally, fears about potential hidden defects and uncertainties surrounding the refurbishment process contribute to this reluctance. It has been noted that original equipment manufacturers (OEMs) often exacerbate these concerns by warning healthcare facilities that they will not provide support for older models, further discouraging the purchase of refurbished devices. As a result, transparency in the refurbishment process and assurances regarding quality and performance are crucial for addressing these perceptions. Without effective strategies to mitigate these concerns, the growth of the refurbished medical imaging equipment market is likely to be hindered.

Category-Wise Acumens

What Factors Contribute to the High Demand for Refurbished MRI Equipment in the Medical Diagnostics Industry?

The substantial cost savings associated with refurbished MRI systems are being recognized as a primary motivator for healthcare facilities, particularly those operating under budget constraints. It has been reported that new MRI machines can cost millions of dollars, making refurbished options, which are typically available at 40% to 60% less than new models, an attractive alternative for hospitals and clinics seeking to maintain high-quality diagnostic capabilities without incurring excessive capital expenditures.

Additionally, the long service life of MRI equipment allows for effective refurbishment, enabling older systems to be updated with modern software and hardware enhancements, thereby extending their usability and performance. According to the World Health Organization (WHO), the increasing prevalence of chronic diseases necessitates advanced imaging solutions, further fueling demand for affordable and reliable MRI equipment.

What Factors Contribute to the Increasing Demand for Refurbished Medical Imaging Equipment Specifically in Oncology Applications?

The increasing demand for refurbished medical imaging equipment in oncology applications is driven by several critical factors. The rising incidence of cancer globally has been documented, with the World Health Organization (WHO) projecting that cancer cases will reach approximately 29.5 million by 2040, necessitating enhanced diagnostic and treatment capabilities. As healthcare facilities strive to provide effective cancer care, the cost- effectiveness of refurbished imaging equipment becomes a significant consideration, especially given that new imaging systems can be prohibitively expensive. It has been reported that refurbished MRI and CT machines can be obtained at 40% to 60% lower prices than their new counterparts, making them accessible for hospitals with limited budgets.

Additionally, advancements in imaging technology have improved the performance and reliability of refurbished devices, ensuring they meet modern clinical standards for precision in cancer diagnosis and treatment planning. Enhanced imaging techniques, such as image- guided radiotherapy and hybrid imaging systems like PET/CT, are increasingly being integrated into oncology practices, further driving the demand for high-quality refurbished equipment capable of supporting these advanced applications. Consequently, the combination of rising cancer prevalence, cost considerations, and technological advancements significantly contributes to the growing demand for refurbished medical imaging equipment within the oncology segment.

Country/Region-wise Acumens

How does the Increasing Prevalence of Chronic Diseases in North America Drive the Demand for Refurbished Medical Imaging Technologies?

The increasing prevalence of chronic diseases in North America is significantly driving the demand for refurbished medical imaging technologies. According to the U.S. National Center for Health Statistics, an estimated 1,958,310 new cancer cases and 609,820 cancer-related deaths were projected in 2023, highlighting the urgent need for effective diagnostic tools. The rising incidence of chronic conditions such as cancer, cardiovascular diseases, and diabetes

necessitates advanced imaging capabilities for accurate diagnosis and treatment planning. It has been reported that approximately 50% of the U.S. population has a chronic disease, which accounts for 86% of healthcare costs, thereby intensifying the demand for affordable imaging solutions. As healthcare facilities face budget constraints, refurbished medical imaging equipment is increasingly viewed as a cost-effective alternative that provides high- quality diagnostic capabilities without the financial burden associated with new devices.

Additionally, advancements in imaging technology have improved the performance of refurbished systems, ensuring they meet contemporary clinical standards. Consequently, the combination of rising chronic disease prevalence, cost considerations, and technological advancements is substantially contributing to the growing demand for refurbished medical imaging technologies in North America.

What Factors Contribute to the Rapid Economic Growth in the Asia Pacific Region that Supports the Refurbished Medical Imaging Equipment Market?

The rapid economic growth in the Asia Pacific region that supports the refurbished medical imaging equipment market is driven by several key factors. The region is home to approximately 60% of the world's population, creating a substantial demand for healthcare services and advanced medical technologies. According to the Asian Development Bank (ADB), healthcare expenditure in the Asia Pacific is projected to increase significantly, with governments aiming to enhance health systems and achieve universal health coverage (UHC). It has been reported that public health spending in East Asia and the Pacific has been declining since 2011, indicating a pressing need for cost-effective solutions like refurbished medical imaging equipment to maximize limited resources.

Additionally, the increasing prevalence of chronic diseases, alongside a growing aging population, necessitates improved diagnostic capabilities, further driving demand for affordable imaging technologies. Government initiatives promoting public-private partnerships (PPPs) are also being recognized as essential for expanding access to healthcare services and facilitating investments in refurbished equipment. These factors collectively contribute to the robust growth of the refurbished medical imaging equipment market in the Asia Pacific region, as healthcare providers seek to enhance their diagnostic capabilities while managing budget constraints effectively.

Competitive Landscape

The competitive landscape of the refurbished medical imaging equipment market is characterized by a combination of specialized refurbishers, original equipment manufacturers (OEMs) selling certified pre-owned devices, and independent service organizations.

Some of the prominent players operating in the refurbished medical imaging equipment market include:

Siemens Healthineers AG

Canon Medical Systems Corporation

Philips Healthcare

GE Healthcare

DRE Medical

Atlantis Worldwide

Block Imaging

Agito Medical A/S

Soma Technology

EBRO Medical Technologies GmbH

EverX Pty Ltd

Shinmed Corporation

Medivison

Avante Health Solutions

Integrity Medical Systems

Refurbished Medical Equipment

Technomed Services

LA Medical Equipment

Biomedical Imaging Services

Latest Development

In May 2023, Siemens Healthineers AG, in partnership with CommonSpirit Health, acquired Block Imaging, Inc., a leading provider of refurbished medical equipment. This acquisition aims to enhance the repair and reuse of medical equipment, thereby reducing waste and increasing value for customers and patients.

In March 2023, GE Healthcare introduced the GoldSeal Discovery ST, a refurbished imaging system that integrates computed tomography (CT) and Positron Emission Tomography (PET). This system is designed to offer advanced imaging capabilities at a more affordable price, catering to healthcare facilities with budget constraints.

Refurbished Medical Imaging Equipment Market, By Category

• Product Type:
• X-ray Devices
• Ultrasound Systems
• CT Scanners
• MRI Equipment
• Others
• Application:
• Oncology
• Cardiovascular
• Gynecology
• Orthopedic
• Others
• End-User:
• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers
• Others
• Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY PRODUCT

• 5.1 Overview
• 5.2 X-ray Devices
• 5.3 Ultrasound Systems
• 5.4 CT Scanners
• 5.5 MRI Equipment
• 5.6 Others

6 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Oncology
• 6.3 Cardiovascular
• 6.4 Gynecology
• 6.5 Orthopedic
• 6.6 Others

7 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Diagnostic Imaging Centers
• 7.4 Ambulatory Care Centers
• 7.5 Other

8 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 GE Healthcare
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Block Imaging
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Agito Medical A/S
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Siemens Healthcare systems
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Integrity Medical Systems
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Koninklijke Philips N.V.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Everx Pvt Ltd.
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 JAPAN CENTRAL MEDICAL, INC
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 CURA Healthcare
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Radiology Oncology Systems, Inc.
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research